Clinical Cardiac Electrophysiology Cardiovascular Disease American Board of Medical Specialties To achieve health for life in Cardiac Arrhythmias ❤️ #LAAclosure
And that’s a wrap! This marks the conclusion of procedures for Phoenix Cardiovascular Research Group (PCVR) for the #CHAMPIONAF clinical trial. Great #LAAO procedure day Abrazo Arizona Heart Hospital performing Boston Scientific Cardiology #Watchman#flx#privatepracticestrong💪
Incredible 7 year journey working with incredible people and helping patients come off a life of blood thinners! Proud to be an Electrophysiologist specializing in #atrialfibrillation and #LAAC#Watchman@BSCCardiology
1st use of the FDA cleared WM FXD curve sheath system in Phoenix/Scottsdale AZ. Doubling the number of wires & optimizing the braid pattern, the WM FXD Curve sheath allows for better torque transmission & improved control during Deployment @BSCCardiology@CViScottsdale#epeeps 💪
Grand Opening of EPIC Surgery of Az, a New #Interventional Cardiology & #EP Center in Scottsdale Arizona. This new Center of Excellence will allow our Cardiologists to fulfill the Mission of Providing Patients State of the Art Healthcare and Compassionate, Personalized Recovery.
We are excited to advance heart care through research by enrolling in The CHAMPION-AF Clinical #Trial studying #WATCHMANFLX as a first line therapy vs #NOAC for #AFib patients who are able to tolerate long-term blood thinners, and consider an option for #Stroke#Prevention
The cornerstones of #atrial fibrillation management are rate control, anticoagulation and rhythm control for those symptomatically limited by AF. FIRST 2 patients treated Combining #watchman FLX #LAAC & catheter ablation for #afib@HonorHealth@BSCCardiology@CViScottsdale
LATE BREAKER: 2-Year Outcomes w/ a Next-Generation #LAAC Device: Final Results From the PINNACLE FLX IDE Trial -#TVT2021#LAAC#afib
-Sustained safety and efficacy outcomes noted w/ Watchman FLX in NVAF patients through 2 years
For patients undergoing Atrial Fibrillation Ablation, the OPTION Clinical trial testing WATCHMAN FLX Left Atrial Appendage Occlusion vs. Oral Anticoagulants May be an option To reduce risk of stroke Learn More: @CViScottsdale#OPTIONtrial#Afib#ablation#stroke#LAAO
I am pleased to announce the much-anticipated publication in @CircAHA of the Primary Endpoint results from the PINNACLE FLX Trial; Primary Outcome Evaluation of a Next Gen #LAAclosure#ahajournals#LAAC@CViScottsdale https://t.co/6wCR8aBSaC
2/2 Also to Be part of the #LAAClosure live case from @LangoneMedicalCenter with distinguished facility including @brijmaini
Operator: Larry Chinitz, MD
Moderators: John M. Lasala, MD, PhD and Brijeshwar S. Maini, MD
@CVIscottsdale#AFIB